Glauconix Biosciences Awarded National Science Foundation Phase IIB Small Business Innovation Research Grant ...Middle East

ALBANY, N.Y., March 23, 2021 /PRNewswire/ -- Glauconix Biosciences, Inc., a specialty pharmaceutical company that uses its patented platform technology to develop human 3D ocular tissues that mimic the fluid dynamics in the eye to expediate and de-risk the R&D of ophthalmic treatments...

Hence then, the article about glauconix biosciences awarded national science foundation phase iib small business innovation research grant was published today ( Tuesday 23/03/2021 - 07:47 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Glauconix Biosciences Awarded National Science Foundation Phase IIB Small Business Innovation Research Grant )

Also on site :

• UnionPay Launches Agentic Payment Open Protocol Framework: Building an Open, Trusted Smart Payment Ecosystem
• Backpack Appoints Nathan Smith as Chief Operating Officer
• Oil Majors Eye U.S. Offshore Asset as Supply Crunch Intensifies